Related Experiment Videos
Non-invasive optical methods for the study of cerebral metabolism in the human newborn: a technique for the future?
Insights
Cerebral ischemia and intraventricular hemorrhage are leading causes of death in preterm newborns. Future fiber-optic spectrophotometry may offer low-cost, noninvasive tools for assessing neonatal cerebral metabolism.
Area of Science:
- Neonatal intensive care
- Neuroscience
- Medical instrumentation
Background:
- Cerebral ischemia and intraventricular hemorrhage are significant causes of mortality and disability in preterm infants.
- Intraventricular hemorrhage affects 40-50% of infants weighing 1500g or less.
- Current methods for assessing cerebral metabolic status are insufficient for continuous monitoring in high-risk neonates.
Purpose of the Study:
- To highlight the need for effective, low-cost instruments for continuous cerebral metabolic assessment in preterm newborns.
- To introduce fiber-optic-based spectrophotometric techniques as a potential solution.
- To emphasize the importance of noninvasive monitoring for preventing death and disability.
Main Methods:
- Review of current challenges in neonatal cerebral monitoring.
- Discussion of the potential of fiber-optic spectrophotometry.
- Exploration of measuring cerebral redox state.
Main Results:
- The lack of effective low-cost instruments hinders the assessment of cerebral ischemia and intraventricular hemorrhage.
- Fiber-optic spectrophotometry offers a promising avenue for noninvasive cerebral metabolism measurement.
- Future development could lead to portable devices for neonatal intensive care.
Conclusions:
- Effective, low-cost tools are crucial for monitoring preterm infant brain health.
- Fiber-optic spectrophotometry holds potential for noninvasive, continuous assessment of cerebral metabolism.
- Advancements in technology can significantly improve outcomes for high-risk neonates.
Abstract:
Two of the major causes of death and disability in the preterm newborn of the developed nations are cerebral ischaemia and intraventricular haemorrhage. It is estimated that intraventricular haemorrhage develops in 40-50% of infants with a birthweight of 1500 g or less but precisely how many individuals are affected by haemorrhage, or how many cases of disability are antedated by cerebral ischaemia, is not known because of the lack of effective low-cost instruments for the continuous, or at least frequent, assessment of cerebral metabolic status in the high-risk individual. In the future, however, fibre-optic-based spectrophotometric techniques for the measurement of cerebral redox state may provide low-cost, portable instruments for the noninvasive assessment of cerebral metabolism during the intensive care of the neonate.